Cellectar Biosciences (CLRB) Announces FDA Exemption to Import Alert for CLR 131 in Pediatric and Adolescent Patients
Tweet Send to a Friend
Cellectar Biosciences, Inc. (NASDAQ: CLRB) today announced that the U.S. Food and Drug Administration (FDA) has granted an exemption to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
